This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Cannabis ETFs: What's Behind the Latest Surge
by Neena Mishra
While marijuana ETFs have seen a recent surge, investors should be aware of the potential risks
4 ETF Zones Beating the Market to Start 2024
by Sweta Killa
We have highlighted few corners of the stock market that are outperforming to start 2024.
5 Best ETF Areas of Last Week
by Sanghamitra Saha
Last week, Wall Street snapped its nine-week win streak, marking the end of their longest consecutive weekly run in the green since 2004.
Cannabis ETFs Spike on Marijuana Classification Review
by Sweta Killa
Marijuana stocks spiked following the report that the US Drug Enforcement Administration (¿¿¿DEA¿¿¿) is reviewing the potential reclassification of cannabis from Schedule I to Schedule III.
5 Best-Performing ETFs of Last Week
by Sanghamitra Saha
Wall Street was moderately upbeat last week and exhibited a decent Santa Clause rally.
Best ETF Areas of Last Week
by Sanghamitra Saha
Wall Street delivered a decent performance last week.
5 ETF Areas That Spooked Investors in October
by Sanghamitra Saha
After a downbeat September, October too remained volatile for Wall Street due to higher rates.
The Zacks Analyst Blog Highlights MLPO, MSOS, URNJ, XES and EVXX
by Zacks Equity Research
MLPO, MSOS, URNJ, XES and EVXX are part of the Zacks top Analyst Blog.
5 Sector ETFs That Beat the Market in Q3
by Sweta Killa
After a solid start to the third quarter, Wall Street lost momentum on fears of higher rates for a longer-than-expected period and a slowing Chinese economy.
Behind the Recent Surge in Marijuana ETFs
by Sanghamitra Saha
In a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.